<DOC>
	<DOC>NCT00743626</DOC>
	<brief_summary>The principal hypothesis of this study is that HPV testing and/or p16 testing, either alone or in combination or associated with a Pap smear, will demonstrate greater specificity for clinically significant precancerous disease than will a Pap smear alone and that these tests will be of comparable or superior sensitivity than the Pap smear.</brief_summary>
	<brief_title>Pap Smear Research Study</brief_title>
	<detailed_description />
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<criteria>18 years and older Ability to speak and clearly understand English Female patients No previous history of Cervical Cancer Treatment(LEEP,Laser,Cone etc.) Women who have had Pap smears within the previous 10 months Women under the age of 18. Women who are pregnant. Inability to give informed consent in English</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>Pap test</keyword>
	<keyword>HPV</keyword>
	<keyword>Healthy patients screened for cervical cancer tests.</keyword>
</DOC>